Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Cryoballoon Ablation Outcomes for Paroxysmal Atrial Fibrillation
Author
Hashmath, Zeba; et al
Date
2022-10-26
Citation:
APA:
Hashmath, Zeba, & et al. (October 2022).
Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Cryoballoon Ablation Outcomes for Paroxysmal Atrial Fibrillation.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/12450
MLA:
Hashmath, Zeba, and et al.
"Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Cryoballoon Ablation Outcomes for Paroxysmal Atrial Fibrillation". .
. (),
October 2022.
April 29, 2024.
http://hdl.handle.net/10342/12450.
Chicago:
Hashmath, Zeba and et al,
"Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Cryoballoon Ablation Outcomes for Paroxysmal Atrial Fibrillation," , no.
(October 2022),
http://hdl.handle.net/10342/12450 (accessed
April 29, 2024).
AMA:
Hashmath, Zeba, et al.
Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Cryoballoon Ablation Outcomes for Paroxysmal Atrial Fibrillation. .
October 2022;
():
.
http://hdl.handle.net/10342/12450. Accessed
April 29, 2024.
Collections